Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.
复制标题

DOI:
10.1586/14737175.2016.1134322
复制
发表时间:
2016
影响因子:
4.3
通讯作者:
Jiang J
Jiang J
中科院分区:
医学3区
文献类型:
--
作者:
Du Y;Kemper T;Qiu J;Jiang J

文献摘要

参考文献

被引文献

相似文献

神经炎症是几乎所有神经系统疾病和一些精神疾病的共同特征。与神经外对应物类似,神经炎症可能是有益的,也可能是有害的,具体取决于反应分子。炎症对疾病进展的总体影响高度依赖于炎症介质产生的程度和炎症诱导的持续时间。炎症反应的时间依赖性表明,抑制神经炎症的治疗时间窗可能随分子靶点和损伤类型的不同而变化。因此,定义抗炎治疗的治疗时间窗非常重要,因为即使在相似的动物模型中使用不同的治疗方案也可能会出现矛盾或阴性结果。在此,我们讨论了一些关键因素,这些因素有助于确定治疗时间窗并优化治疗模式,以抑制癫痫持续状态后环氧合酶-2/前列腺素介导的炎症。这些决定因素也应该与中枢神经系统疾病的其他抗炎治疗策略相关。
Neuroinflammation is a common feature in nearly all neurological and some psychiatric disorders. Resembling its extraneural counterpart, neuroinflammation can be both beneficial and detrimental depending on the responding molecules. The overall effect of inflammation on disease progression is highly dependent on the extent of inflammatory mediator production and the duration of inflammatory induction. The time-dependent aspect of inflammatory responses suggests that the therapeutic time window for quelling neuroinflammation might vary with molecular targets and injury types. Therefore, it is important to define the therapeutic time window for anti-inflammatory therapeutics, as contradicting or negative results might arise when different treatment regimens are utilized even in similar animal models. Herein, we discuss a few critical factors that can help define the therapeutic time window and optimize treatment paradigm for suppressing the cyclooxygenase-2/prostaglandin-mediated inflammation after status epilepticus. These determinants should also be relevant to other anti-inflammatory therapeutic strategies for the CNS diseases.
DOI: 10.1016/j.nbd.2014.12.032
发表时间: 2015-04
影响因子: 6.1
作者:
Jiang, Jianxiong;Yang, Myung-Soon;Quan, Yi;Gueorguieva, Paoula;Ganesh, Thota;Dingledine, Raymond
通讯作者: Dingledine, Raymond
DOI: 10.1016/j.eplepsyres.2008.12.006
发表时间: 2009-03-01
期刊: EPILEPSY RESEARCH
影响因子: 2.2
作者:
Holtman, L.;van Vliet, E. A.;Gorter, J. A.
通讯作者: Gorter, J. A.
DOI: 10.1016/j.eplepsyres.2010.06.011
发表时间: 2010-09-01
期刊: EPILEPSY RESEARCH
影响因子: 2.2
作者:
Holtman, Linda;van Vliet, Erwin A.;Gorter, Jan A.
通讯作者: Gorter, Jan A.
DOI: 10.1002/cne.21974
发表时间: 2009-04-10
影响因子: 2.5
作者:
Azevedo, Frederico A. C.;Carvalho, Ludmila R. B.;Herculano-Houzel, Suzana
通讯作者: Herculano-Houzel, Suzana
DOI: 10.1016/j.nbd.2006.02.016
发表时间: 2006-08-01
影响因子: 6.1
作者:
Jung, Keun-Hwa;Chu, Kon;Roh, Jae-Kyu
通讯作者: Roh, Jae-Kyu